GEN2d
C3i Center Receives EMA Approval to Manufacture Cell Therapy Products for Europe
C3i obtained a Drug Establishment License (DEL) to produce cell therapies for patients across Canada commercially.
Canadian Manufacturing2d
C3i to manufacture cell therapy products for European market
MONTRÉAL — C3i Center obtains regulatory approval from the EMA (European Medicine Agency) to produce cell therapy treatments for the European market. C3i, therefore, obtains a certificate of GMP ...
C3i Center, a Canadian company, receives approval from the EMA to manufacture cell therapy products for the European market
The company received a certificate of Good Manufacturing Practice (GMP) compliance following an inspection of their Montreal facility by the European Medicines AgencyMONTRÉAL, Feb. 19, 2025 (GLOBE ...